Daniel Bensen Sells 745 Shares of Tyra Biosciences, Inc. Stock

TYRA Stock  USD 15.68  0.32  2.00%   
About 56% of Tyra Biosciences' investor base is looking to short. The analysis of the overall investor sentiment regarding Tyra Biosciences suggests that many traders are alarmed. The current market sentiment, together with Tyra Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Tyra Biosciences stock news signals to limit their universe of possible portfolio assets.
  
Tyra Biosciences, Inc. COO Daniel Bensen sold 745 shares of Tyra Biosciences stock in a transaction dated Tuesday, February 27th. The shares were sold at an average price of 20.00, for a total value of 14,900.00. Following the sale, the chief operating officer now directly owns 450,735 shares in the

Read at thelincolnianonline.com
news
  

Tyra Biosciences Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Tyra Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Tyra Biosciences Fundamental Analysis

We analyze Tyra Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tyra Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tyra Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Beta

Beta Comparative Analysis

Tyra Biosciences is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Tyra Biosciences Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tyra Biosciences stock to make a market-neutral strategy. Peer analysis of Tyra Biosciences could also be used in its relative valuation, which is a method of valuing Tyra Biosciences by comparing valuation metrics with similar companies.

Peers

Tyra Biosciences Related Equities

GLUEMonte Rosa   13.72   
0%
100.0%
CCCCC4 Therapeutics   8.59   
0%
62.0%
XLOXilio Development   7.92   
0%
57.0%
IPSCCentury Therapeutics   5.52   
0%
40.0%
CNTBConnect Biopharma   2.91   
0%
21.0%
CGEMCullinan Oncology   2.75   
0%
20.0%
EWTXEdgewise Therapeutics   2.48   
0%
18.0%
RAPTRAPT Therapeutics   2.44   
0%
17.0%
IKNAIkena Oncology   2.37   
0%
17.0%
STOKStoke Therapeutics   1.68   
0%
12.0%
HOWLWerewolf Therapeutics   1.52   
0%
11.0%
PMVPPmv Pharmaceuticals   1.25   
0%
9.0%
DSGNDesign Therapeutics   0.50   
0%
3.0%
MOLNMolecular Partners   0.17   
1.0%
0%
ERASErasca   2.05   
14.0%
0%
PHVSPharvaris   2.06   
15.0%
0%
MLYSMineralys Therapeutics,   2.59   
18.0%
0%

Complementary Tools for Tyra Stock analysis

When running Tyra Biosciences' price analysis, check to measure Tyra Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tyra Biosciences is operating at the current time. Most of Tyra Biosciences' value examination focuses on studying past and present price action to predict the probability of Tyra Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tyra Biosciences' price. Additionally, you may evaluate how the addition of Tyra Biosciences to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Commodity Directory
Find actively traded commodities issued by global exchanges
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios